Lucien H. J. Schreiber

ORCID: 0009-0003-8586-240X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • 3D Printing in Biomedical Research
  • Tissue Engineering and Regenerative Medicine
  • Diabetes Management and Research
  • Pancreatic function and diabetes
  • Polymer Surface Interaction Studies
  • Electrospun Nanofibers in Biomedical Applications
  • Cellular Mechanics and Interactions
  • Soft Robotics and Applications
  • Diabetes and associated disorders

Ollscoil na Gaillimhe – University of Galway
2021-2023

Explora (Italy)
2021

The foreign body response impedes the function and longevity of implantable drug delivery devices. As a dense fibrotic capsule forms, integration device with host tissue becomes compromised, ultimately resulting in seclusion treatment failure. We present FibroSensing Dynamic Soft Reservoir (FSDSR), an capable monitoring formation overcoming its effects via soft robotic actuations. Occlusion FSDSR porous membrane was monitored over 7 days rodent model using electrochemical impedance...

10.1126/scirobotics.abq4821 article EN Science Robotics 2023-08-30

The foreign body response (FBR) to implanted materials culminates in the deposition of a hypo-permeable, collagen rich fibrotic capsule by myofibroblast cells at implant site. can be deleterious function some medical implants as it isolate from host environment. Modulation formation has been achieved using intermittent actuation drug delivery implants, however mechanisms underlying this are not well understood. Here, we use analytical, computational, and vitro models understand human...

10.1016/j.actbio.2023.11.017 article EN cc-by-nc-nd Acta Biomaterialia 2023-11-14

Duffy Lab Group, National University of Ireland Galway. Introduction: Over 60% islets transplanted in macrodevices are lost immediately post transplantation due to hypoxia from inadequate early vascularisation [1][2][3]. Prevascularisation the implant site by spatiotemporally delivering vascular endothelial growth factor (VEGF), most prominent angiogenic [4], is a potential solution [5]. VEGF has half-life only 50 mins at body temperature [6][7] meaning multiple, large doses required if...

10.1097/01.tp.0000804568.54768.83 article EN Transplantation 2021-11-24
Coming Soon ...